Quinidine Gluconate
Click to View Image
C20H24N2O2·C6H12O7 520.57

Cinchonan-9-ol, 6¢-methoxy-, (9S)-, mono-d-gluconate (salt)
Quinidine mono-d-gluconate (salt) [7054-25-3].
» Quinidine Gluconate is the gluconate of an alkaloid that may be obtained from various species of Cinchona and their hybrids, or from Remijia pedunculata Flückiger (Fam. Rubiaceae), or prepared from quinine. Quinidine Gluconate contains not less than 99.0 percent and not more than 100.5 percent of total alkaloid salt, calculated as C20H24N2O2·C6H12O7, on the dried basis.
Packaging and storage— Preserve in well-closed, light-resistant containers. Store at 25, excursions permitted between 15 and 30.
A: A 1 in 2000 solution in dilute sulfuric acid (1 in 350) exhibits a vivid blue fluorescence. On the addition of a few drops of hydrochloric acid, the fluorescence disappears.
B: In the test for Chromatographic purity, the RF value of the principal spot obtained from the Test preparation corresponds to that from the Standard preparation.
C: A solution (1 in 50) is dextrorotatory.
D: Dissolve 700 mg in 5 mL of water with the aid of heat, and add 1 mL of glacial acetic acid and 200 mg of phenylhydrazine hydrochloride. Heat in a water bath for 15 minutes, cool, and scratch the inner surface of the tube with a glass rod: orange crystals are formed.
Loss on drying 731 Dry it at 105 for 1 hour: it loses not more than 0.5% of its weight.
Residue on ignition 281: not more than 0.15%.
Limit of dihydroquinidine gluconate—
Methanesulfonic acid solution— Add 35.0 mL of methanesulfonic acid to 20.0 mL of glacial acetic acid, dilute with water to 500 mL, and mix.
Diethylamine solution— Dissolve 10.0 mL of diethylamine in water to obtain 100 mL of solution.
Mobile phase— Prepare a filtered and degassed mixture of water, acetonitrile, Methanesulfonic acid solution, and Diethylamine solution (860:100:20:20). Adjust with Diethylamine solution to a pH of 2.6.
System suitability solution— Transfer about 10 mg each of quinidine gluconate and dihydroquinidine hydrochloride to a 50-mL volumetric flask. Dissolve in about 5 mL of methanol, dilute with Mobile phase to volume, and mix.
Test solution— Transfer about 26 mg of Quinidine Gluconate to a 100-mL volumetric flask, dissolve in and dilute with Mobile phase to volume, and mix.
Chromatographic system (see Chromatography 621)— The liquid chromatograph is equipped with a 235-nm detector and a 3.9-mm × 30-cm column that contains packing L1. Chromatograph the System suitability solution, and proceed as directed for Procedure: the relative retention times for quinidine and dihydroquinidine are 1 and 1.5, respectively; the resolution, R, between the quinidine and dihydroquinidine is not less than 2.5; and the relative standard deviation for the peak response is not more than 2.0%.
Procedure— Inject about 50 µL of the Test solution into the chromatograph, record the chromatogram, and measure the peak responses. The response of the dihydroquinidine peak is not greater than 0.25 that of the quinidine peak (20.0%).
Chromatographic purity—
Standard preparation— Prepare a solution of USP Quinidine Gluconate RS in diluted alcohol to contain 6 mg per mL.
Diluted standard preparation— Dilute a portion of the Standard preparation with diluted alcohol to a concentration of 0.06 mg per mL.
Related substances preparation— Prepare a solution in diluted alcohol containing in each mL 0.04 mg of USP Quininone RS (corresponding to 0.06 mg of the gluconate), and 0.08 mg of cinchonine (corresponding to 0.12 mg of the gluconate).
Test preparation— Prepare a solution of Quinidine Gluconate in diluted alcohol to contain 6 mg per mL.
Procedure— Apply 10-µL portions of the Test preparation, the Standard preparation, the Diluted standard preparation, and the Related substances preparation to a suitable thin-layer chromatographic plate (see Chromatography 621) coated with a 0.25-mm layer of chromatographic silica gel. Allow to dry, and develop the chromatogram in a solvent system consisting of a mixture of chloroform, acetone, and diethylamine (5:4:1), the solvent chamber being used without previous equilibration. When the solvent front has moved about 15 cm, remove the plate from the chamber, mark the solvent front, and allow the solvent to evaporate. Spray the chromatogram with glacial acetic acid. Locate the spots on the plate by examination under long-wavelength UV light. Any spot produced by the Test preparation at the RF value of a spot produced by the Related substances preparation is not greater in size or intensity than that corresponding spot. Apart from these spots and from the spots appearing at the RF value of Quinidine Gluconate and dihydroquinidine gluconate (the two spots most evident from the Standard preparation), any additional fluorescent spot is not greater in size or intensity than the principal spot of the Diluted standard preparation. Spray the plate with potassium iodoplatinate TS. Any spot produced by the Test preparation is not greater in size or intensity than a corresponding spot from the Related substances preparation.
Assay— Dissolve about 150 mg of Quinidine Gluconate, accurately weighed, in 10 mL of glacial acetic acid, heating gently if necessary. Cool the solution, add 20 mL of acetic anhydride and 4 drops of p-naphtholbenzein TS, and titrate with 0.1 N perchloric acid VS from a 10-mL microburet to a green endpoint. Perform a blank determination, and make any necessary correction. Each mL of 0.1 N perchloric acid is equivalent to 26.03 mg of total alkaloid salt, calculated as C20H24N2O2·C6H12O7.
Auxiliary Information— Please check for your question in the FAQs before contacting USP.
Topic/Question Contact Expert Committee
Monograph Sujatha Ramakrishna, Ph.D.
(MDCV05) Monograph Development-Cardiovascular
Reference Standards Lili Wang, Technical Services Scientist
USP32–NF27 Page 3460
Pharmacopeial Forum: Volume No. 29(5) Page 1568
Chromatographic Column—
Chromatographic columns text is not derived from, and not part of, USP 32 or NF 27.